Acorda Therapeutics Inc PEG
Was ist das PEG von Acorda Therapeutics Inc?
PEG von Acorda Therapeutics Inc ist N/A
Was ist die Definition von PEG?
Das Kurs-Gewinn-Wachstums-Verhältnis (PEG) ist das KGV einer Aktie geteilt durch eine erwartete Wachstumsrate des Gewinns über einen Zeitraum von 5 Jahren.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit peg ähnlich Acorda Therapeutics Inc
- Mallinckrodt Plc hat PEG von N/A
- HighPoint Resources Corp hat PEG von N/A
- Adamas Pharmaceuticals Inc hat PEG von N/A
- Pivot Technology Solutions hat PEG von N/A
- Copper Mountain Mining hat PEG von N/A
- SITO Mobile hat PEG von N/A
- Acorda Therapeutics Inc hat PEG von N/A
- RumbleON Inc hat PEG von N/A
- Endologix hat PEG von N/A
- Alto Ingredients Inc hat PEG von N/A
- Sunesis Pharmaceuticals Inc hat PEG von N/A
- Unit hat PEG von N/A
- Pacific Drilling SA hat PEG von N/A